Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Omega Pharma NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3337
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company’s product portfolio includes cough and cold products, skin care products, pain relief products, vitamins, minerals, and nutritional supplements. Its products cater to gastro-intestinal disorders, respiratory issues, eye care, weight management, food supplements, baby care, and skin care. Besides, the company offers auto-diagnostic products such as body temperature meters, ovulation meters and blood pressure meters. It distributes these products to customers through retail distribution and drug store chains. Omega Pharma is headquartered in Nazareth, Belgium.

Omega Pharma NV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Omega Pharma NV, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Omega Pharma Acquires Arterin Business Of Pharco For US$13 Million 11
Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 12
Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For US$614 Million 13
Partnerships 15
Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 15
NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 16
Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 17
Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 18
Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 19
Licensing Agreements 20
Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 20
BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 21
Equity Offering 22
Omega Pharma Completes Public Offering Of Shares For US$237 Million 22
Debt Offering 23
Omega Pharma Completes Public Offering Of Bonds Due 2017 For US$383 Million 23
Omega Pharma Completes Public Offering Of Bonds Due 2017 For US$237.6 Million 24
Omega Pharma Completes Public Offering Of Bonds Due 2019 For US$158.4 Million 25
Acquisition 26
Perrigo Acquires Omega Pharma for USD4.76 Billion 26
Omega Pharma Acquires Naturoteek 28
Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For US$1.26 Billion 29
Omega Pharma NV – Key Competitors 31
Omega Pharma NV – Key Employees 32
Omega Pharma NV – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Omega Pharma NV, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Omega Pharma NV, Deals By Therapy Area, 2012 to YTD 2018 8
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Omega Pharma Acquires Arterin Business Of Pharco For US$13 Million 11
Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 12
Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For US$614 Million 13
Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 15
NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 16
Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 17
Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 18
Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 19
Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 20
BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 21
Omega Pharma Completes Public Offering Of Shares For US$237 Million 22
Omega Pharma Completes Public Offering Of Bonds Due 2017 For US$383 Million 23
Omega Pharma Completes Public Offering Of Bonds Due 2017 For US$237.6 Million 24
Omega Pharma Completes Public Offering Of Bonds Due 2019 For US$158.4 Million 25
Perrigo Acquires Omega Pharma for USD4.76 Billion 26
Omega Pharma Acquires Naturoteek 28
Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For US$1.26 Billion 29
Omega Pharma NV, Key Competitors 31
Omega Pharma NV, Key Employees 32
Omega Pharma NV, Subsidiaries 33
Omega Pharma NV, Joint Venture 34

List of Figures
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • Themis Medicare Ltd (THEMISMED):企業の財務・戦略的SWOT分析
    Summary Themis Medicare Ltd (Themis Medicare), a subsidiary of Gedeon Richter Plc is a differentiated injectables developer that manufactures and markets pharmaceutical and healthcare products. The company’s products include formulations, original products, active pharmaceutical ingredients and diet …
  • Plansee Holding AG:企業の戦略・SWOT・財務情報
    Plansee Holding AG - Strategy, SWOT and Corporate Finance Report Summary Plansee Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Allen-Vanguard Corp:企業の戦略・SWOT・財務分析
    Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report Summary Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Vigo Coal Company Incorporated:企業の戦略・SWOT・財務情報
    Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sirius XM Radio Inc. (SIRI):企業の財務・戦略的SWOT分析
    Sirius XM Radio Inc. (SIRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Gulf Oil Limited Partnership:企業の戦略・SWOT・財務情報
    Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ferguson Enterprises Inc:企業の戦略的SWOT分析
    Ferguson Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Atrium Innovations Inc:企業の戦略的SWOT分析
    Atrium Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Palram Industries Ltd (PLRM):企業の財務・戦略的SWOT分析
    Palram Industries Ltd (PLRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Martin Midstream Partners LP (MMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Martin Midstream Partners LP (Martin Midstream) is a midstream service provider that carries out the transportation, storage and distribution of petroleum products and by-products. Its service offerings include terminalling, transportation, distribution, and midstream logistical services, be …
  • Ming Fai International Holdings Limited:企業の戦略・SWOT・財務情報
    Ming Fai International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Ming Fai International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Prothena Corp Plc (PRTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • BBA Aviation plc:企業の戦略・SWOT・財務情報
    BBA Aviation plc - Strategy, SWOT and Corporate Finance Report Summary BBA Aviation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bureau Veritas SA:企業の戦略・SWOT・財務情報
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆